Standout Papers

Humanization of an anti-p185HER2 antibody for human cancer therapy. 1989 2026 2001 2013 1.4k
  1. Humanization of an anti-p185HER2 antibody for human cancer therapy. (1992)
    Paul Carter, Leonard G. Presta et al. Proceedings of the National Academy of Sciences
  2. Identification of Heregulin, a Specific Activator of p185 erbB2 (1992)
    William E. Holmes, Mark X. Sliwkowski et al. Science
  3. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu (1992)
    Christopher C. Benz, Gary K. Scott et al. Breast Cancer Research and Treatment
  4. p185HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor (1989)
    Robert M. Hudziak, Gail D. Lewis Phillips et al. Molecular and Cellular Biology

Immediate Impact

11 by Nobel laureates 39 from Science/Nature 83 standout
Sub-graph 1 of 16

Citing Papers

The Basis of Oncoimmunology
2016 Standout
Multidrug evolutionary strategies to reverse antibiotic resistance
2015 StandoutScience
1 intermediate paper

Works of H. Michael Shepard being referenced

NB2001, a Novel Antibacterial Agent with Broad-Spectrum Activity and Enhanced Potency against β-Lactamase-Producing Strains
2002
Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic
1991

Author Peers

Author Last Decade Papers Cites
H. Michael Shepard 4723 3717 4457 63 9.1k
B M Fendly 3891 3008 3469 59 7.6k
S A Aaronson 3082 1288 5823 97 9.5k
Ralph Schwall 2634 1407 6053 85 10.1k
Joy Burchell 2466 3923 9221 129 12.1k
Gerhard Moldenhauer 2623 1777 3308 129 7.5k
Y. Gloria Meng 2186 3639 4800 47 8.5k
Joel S. Hayflick 1852 1083 4333 42 7.9k
Jay C. Unkeless 1493 2595 4287 89 11.0k
Roger M. Perlmutter 3380 2345 5880 124 13.1k
Raphael Clynes 2681 3689 2829 97 11.0k

All Works

Loading papers...

Rankless by CCL
2026